Except as provided in Rule 0400-20-07-.26, a licensee shall require the authorized nuclear pharmacist to be a pharmacist who:

(1) Is certified by a specialty board whose certification process has been recognized by the Division, the U.S. Nuclear Regulatory Commission or an Agreement State and who meets the requirements in subparagraph (2)(b) of this rule. To be recognized, a specialty board shall require all candidates for certification to:
(a) Have graduated from a pharmacy program accredited by the American Council on Pharmaceutical Education (ACPE) or have passed the Foreign Pharmacy Graduate Examination Committee (FPGEC) examination;
(b) Hold a current, active license to practice pharmacy;
(c) Provide evidence of having acquired at least 4,000 hours of training/experience in nuclear pharmacy practice. Academic training may be substituted for no more than 2,000 hours of the required training and experience; and
(d) Pass an examination in nuclear pharmacy administered by diplomates of the specialty board, which assesses knowledge and competency in procurement, compounding, quality assurance, dispensing, distribution, health and safety, radiation safety, provision of information and consultation, monitoring patient outcomes, research and development; or
(a) Has completed 700 hours in a structured educational program consisting of both:
1. 200 hours of classroom and laboratory training in the following areas:
(i) Radiation physics and instrumentation;
(ii) Radiation protection;
(iii) Mathematics pertaining to the use and measurement of radioactivity;
(iv) Chemistry of radioactive material for medical use; and
(v) Radiation biology; and
2. Supervised practical experience in a nuclear pharmacy involving:
(i) Shipping, receiving, and performing related radiation surveys;
(ii) Using and performing checks for proper operation of instruments used to determine the activity of dosages, survey meters, and, if appropriate, instruments used to measure alpha-or beta-emitting radionuclides;
(iii) Calculating, assaying, and safely preparing dosages for patients or human research subjects;
(iv) Using administrative controls to avoid misadministrations in the administration of radioactive material; and
(v) Using procedures to prevent or minimize radioactive contamination and using proper decontamination procedures; and
(b) Has obtained written attestation, signed by a preceptor authorized nuclear pharmacist, that the individual has satisfactorily completed the requirements in subparagraphs (1)(a) through (d) or subparagraph (2)(a) of this rule and has achieved a level of competency sufficient to function independently as an authorized nuclear pharmacist.


Tenn. Comp. R. & Regs. 0400-20-07-.25
Original rule filed February 22, 2012; effective May 22, 2012.

Authority: T.C.A. §§ 68-202-101 et seq., 68-202-201 et seq. and 4-5-201 et seq.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.

No prior version found.